GZ17-6.02
Pancreatic Cancer, Head and Neck Cancer, Metastatic Breast Cancer
Key Facts
About Genzada Pharmaceuticals
Genzada Pharmaceuticals is a private, preclinical to early clinical-stage biotech focused on developing oncology therapeutics from natural product sources. Its core technology platform centers on the systematic identification and pharmaceutical optimization of bioactive plant compounds, with a lead asset, GZ17-6.02, having entered Phase 1 clinical trials. The company operates with a lean 'Little Pharma, Big Science' model, leveraging academic collaborations to advance its pipeline targeting cancers with high unmet need, such as pancreatic and head and neck cancers. Founded by chemist Gene Zaid, Genzada is pre-revenue and is building its intellectual property portfolio around its novel formulations.
View full company profile